Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine5′-monophosphate deaminase inhibitors

被引：0
|
作者：
Kasibhatla, SR [1 ]
Bookser, BC [1 ]
Appleman, JR [1 ]
Probst, G [1 ]
Xiao, W [1 ]
Fujitaki, JM [1 ]
Erion, MD [1 ]
机构：
[1] Metabasis Therapeut Inc, San Diego, CA 92121 USA
来源：
PURINE AND PYRIMIDINE METABOLISM IN MAN IX | 1998年 / 431卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：849 / 852
页数：4
相关论文
共 50 条
  • [31] Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3-Alkylindole Derivatives as Selective and Highly Potent Myeloperoxidase Inhibitors
    Soubhye, Jalal
    Aldib, Iyas
    Elfving, Betina
    Gelbcke, Michel
    Furtmueller, Paul G.
    Podrecca, Manuel
    Conotte, Raphael
    Colet, Jean-Marie
    Rousseau, Alexandre
    Reye, Florence
    Sarakbi, Ahmad
    Vanhaeyerbeek, Michel
    Kauffmann, Jean-Michel
    Obinger, Christian
    Neve, Jean
    Prevost, Martine
    Boudjeltia, Karim Zouaoui
    Dufrasne, Francois
    Van Antwerpen, Pierre
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 3943 - 3958
  • [32] Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation
    Yu, Mingfeng
    Teo, Theodosia
    Yang, Yuchao
    Li, Manjun
    Long, Yi
    Philip, Stephen
    Noll, Benjamin
    Heinemann, Gary K.
    Diab, Sarah
    Eldi, Preethi
    Mekonnen, Laychiluh
    Anshabo, Abel T.
    Rahaman, Muhammed H.
    Milne, Robert
    Hayball, John D.
    Wang, Shudong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214
  • [33] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [34] Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors
    Terasaka, T
    Kinoshita, T
    Kuno, M
    Seki, N
    Tanaka, K
    Nakanishi, I
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) : 3730 - 3743
  • [35] Design, synthesis, and structure-activity relationships of potent factor Xa inhibitors with benzimidazole as a central template.
    Huang, WR
    Fan, JM
    Jia, ZHJ
    Wong, P
    Tran, K
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
  • [36] Design, synthesis, and structure-activity relationships of potent factor Xa inhibitors with benzoxazinone as a central template.
    Huang, WR
    Wang, LY
    Zhang, PL
    Fan, JM
    Wong, P
    Tran, K
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
  • [37] Structure-Activity Relationships of Orotidine-5′-Monophosphate Decarboxylase Inhibitors as Anticancer Agents
    Bello, Angelica M.
    Konforte, Danijela
    Poduch, Ewa
    Furlonger, Caren
    Wei, Lianhu
    Liu, Yan
    Lewis, Melissa
    Pai, Emil F.
    Paige, Christopher J.
    Kotra, Lakshmi P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) : 1648 - 1658
  • [38] Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors
    Han, Xin
    Sun, Ningyuan
    Wu, Haoming
    Guo, Deyin
    Tien, Po
    Dong, Chune
    Wu, Shuwen
    Zhou, Hai-Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 2139 - 2150
  • [39] Design and Structure-Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors
    Malamas, Michael S.
    Pavlopoulos, Spiro
    Alapafuja, Shakiru O.
    Farah, Shrouq, I
    Zvonok, Alexander
    Mohammad, Khadijah A.
    West, Jay
    Perry, Nicholas Thomas
    Pelekoudas, Dimitrios N.
    Rajarshi, Girija
    Shields, Christina
    Chandrashekhar, Honrao
    Wood, Jodi
    Makriyannis, Alexandros
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (09) : 5956 - 5972
  • [40] Structure-activity relationships of novel, highly potent, selective, and orally active CCRI antagonists
    Xie, Yun Feng
    Lake, Kirk
    Ligsay, Kathleen
    Komandla, Mallareddy
    Sircar, Ila
    Nagarajan, Gobi
    Li, Jian
    Xu, Kui
    Parise, Jason
    Schneider, Lisa
    Huang, Ding
    Liu, Juping
    Dines, Kevin
    Sakurai, Naoki
    Barbosa, Miguel
    Jack, Rick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3367 - 3372
12345